Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)

The use of selective serotonin reuptake inhibitors, or SSRIs, for people with autism has been investigated in a Cochrane review. Two of the authors, Katrina Williams from the University of New South Wales and Sydney Children’s Hospital, and Philip Hazell from Sydney Medical School in Australia describe the findings.